Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company", "Kane Biotech") announces today that it has entered into a binding term sheet (the "Term ...

Daniel Baker, M.D., will join Cue Biopharma's executive team as interim chief development officer (CDO), effective Monday, November 25, 2024Anish Suri, Ph.D., president & chief scientific officer (CSO ...

Food and Drug Administration’s blessing to fast-track its vision technology, called Blindsight, through the regulatory ...

The new rules instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

The new rules become binding on November 20, but many drug companies have already been acting within these requirements.

FILE PHOTO: Dr. Ben Carson sits in as Republican presidential candidate and former U.S. President Donald Trump calls in to a ...

Clinical development and trial testing of vesleteplirsen (SRP-5051) for Duchenne muscular dystrophy (DMD) was stopped, with ...

Lots of people swear they’re going to give up cigarettes for good.Maybe it’s a New Year’s resolution or just a desire to get ...

The day after the election, some celebrated Trump's win and RFK Jr.'s potential role as a public health decision-maker. Why?

The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

to “go wild” on medicines, food, and health ... changes,” former FDA chief counsel Dan Troy said. But the administration ...